APA (7th ed.) Citation

LM, B., A, B., A, L., M, V., SE, G., S, A., . . . LH, L. (2025). Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma. Cancer immunology, immunotherapy : CII, 74(6), 174. https://doi.org/10.1007/s00262-025-04029-9

Chicago Style (17th ed.) Citation

LM, Berclaz, et al. "Durable Response to Nivolumab in Combination with Regional Hyperthermia in a Patient with PD-L1-negative Metastatic Head and Neck Squamous Cell Carcinoma." Cancer Immunology, Immunotherapy : CII 74, no. 6 (2025): 174. https://doi.org/10.1007/s00262-025-04029-9.

MLA (9th ed.) Citation

LM, Berclaz, et al. "Durable Response to Nivolumab in Combination with Regional Hyperthermia in a Patient with PD-L1-negative Metastatic Head and Neck Squamous Cell Carcinoma." Cancer Immunology, Immunotherapy : CII, vol. 74, no. 6, 2025, p. 174, https://doi.org/10.1007/s00262-025-04029-9.